South Korea General Anesthesia Market Report and Forecast 2024-2032

According to the report, the South Korea general anaesthesia market is projected to grow at a CAGR of 4.5% between 2024 and 2032 reaching a value of around USD 120.35 million by 2032. Aided by the increase in surgeries and diagnostic procedures and escalating demand for safe and effective anaesthetics, the market is expected to grow significantly by 2032.

General anaesthesia is a medically induced coma, often achieved by a balanced combination of intravenous drugs and inhaled gasses. It is used during surgeries to control pain, maintain unconsciousness, regulate breathing, and stabilise the heart rate and blood pressure. The primary goal is to ensure patients do not feel any physical distress during surgical operations.

The South Korea general anaesthesia market growth is being driven by an increasing consumer preference for safe and effective anaesthesia during surgical procedures. With the rising awareness about the advantages of general anaesthesia, including complete unconsciousness, pain control, and muscle relaxation, there has been a significant shift towards general anaesthesia, resulting in a surge in demand.

Moreover, the escalating number of surgical procedures owing to the ageing population, increasing prevalence of chronic diseases, and advances in surgical techniques have further driven the South Korea general anaesthesia market demand. General anaesthesia is used in various surgeries ranging from routine procedures such as gallbladder removal and hernia repair to more complex operations like heart surgery and organ transplants.

The pharmaceutical industry plays a crucial role in driving the general anaesthesia market. The development of new and improved anaesthetic drugs with fewer side effects, faster onset of action, and quicker recovery times has revolutionised anaesthesia delivery and enhanced patient outcomes. This constant innovation and drug development in the pharmaceutical industry contribute significantly to the South Korea general anaesthesia market outlook.

Further, the advent and adoption of sophisticated anaesthesia delivery systems, such as anaesthesia machines with integrated monitors and alarms, and advanced ventilatory modes, have streamlined anaesthesia administration and improved patient safety. This technological advancement is another critical factor propelling the market growth.

Lastly, the rising trend of outpatient surgeries and the growing popularity of minimally invasive procedures have boosted the demand for short-acting anaesthetic agents, thus spurring the South Korea general anaesthesia market expansion. Furthermore, the increasing emphasis on pain management in post-operative care is expected to provide additional impetus to the market growth.

Market Segmentation

The market can be divided based on drug type, route of administration, surgery type, and end use.

Market Breakup by Drug Type

• Propofol
• Sevoflurane
• Desflurane
• Dexmedetomidine
• Others

Market Breakup by Route of Administration

• Intravenous
• Inhalation

Market Breakup by Surgery Type

• Heart Surgery
• Cancer Surgery
• Knee and Hip Replacements
• General Surgery
• Others

Market Breakup by End Use

• Hospitals
• Ambulatory Surgical Centres

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the South Korea general anaesthesia market. Some of the major players explored in the report are as follows:

• Fresenius Kabi Korea Ltd
• Hana Pharm Co., Ltd.
• Daewon Pharmaceutical Co., Ltd
• Pfizer Ltd.
• Baxter International Inc.
• AbbVie Inc.
• Others